Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies-Reference-Cited by-同舟云学术

Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies

Published:2010-04 Issue:2 Volume:7 Page:88-108
ISSN:1550-8579
Container-title:Gender Medicine
language:en
Short-container-title:Gender Medicine

Author:

MacGregor E. Anne,Pawsey Stephen P.,Campbell John C.,Hu Xiaojun

Publisher

Elsevier BV

Subject

General Medicine,Gender Studies

Reference60 articles.

1. Migraine prevalence, disease burden, and the need for preventive therapy;Lipton;Neurology,2007

2. The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity;Steiner;Cephalalgia,2003

3. Epidemiology of headache in Europe;Stovner;Eur j Neurol,2006

4. Cumulative lifetime migraine incidence in women and men;Stewart;Cephalalgia,2008

5. The global burden of migraine: Measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF);Leonardi;J Headache Pain,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine;Cephalalgia;2024-08

2. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis;Acta Pharmacologica Sinica;2019-02-27

3. Prevention of Migraine;JAMA;2017-06-06

4. Triptans and migraine: advances in use, administration, formulation, and development;Expert Opinion on Pharmacotherapy;2017-02-14

5. Gender-Based Issues in Headache;Headache and Migraine Biology and Management;2015